InvestorsHub Logo
Followers 22
Posts 6964
Boards Moderated 0
Alias Born 03/18/2015

Re: drivepact post# 21546

Sunday, 08/16/2015 9:51:32 PM

Sunday, August 16, 2015 9:51:32 PM

Post# of 128636
Canopy Growth Corporation sounds perfect to me. Anyways the LP's will remain the same, same brands, etc, etc.

one thing i know for sure, i wouldn't want Bruce Linton taking advise from anyone that invested when the price was significantly above $2 a share, he would rather take your money to start a successful business, your advise he don't need

Tweed is cool because it rhymes with weed, i like it but doctors and researchers...Tweed was a start-up run by a mischievous little weasel named Chuck, great brand, now time to get serious

Remember, Bedrocan Canada has a really nice license deal with Bedrocan BV. Bedrocan BV has been working hard on creating a consistent pharmaceutical product, working on the science behind the cannabanoids, behind a small group of strains, these are not strains - its a single genetic lineage, the entire production of Bedrocan Cannabis is all cloned - it is all literally one plant for each product they have - they just keep cutting and growing the same exact plant, studying it

They produce it is a very controlled environment - the point is not that it is the best production method - they are growing these genetically identical plants in the exact same way with the exact same environmental conditions both in Canada and in Hollande - so - a gram of Bedrocan Canada cannabis is the exact same thing as a gram of BV Cannabis.

This strategy is more than just for patients, if you are a cannabis researcher - where do you want to get a controlled product in order to do your study? - this is all about developing superior INTELLECTUAL PROPERTY - Started up and headed by our NEW PARTNERS in Hollande, they exported the brand and the IP to Canada, they sought out partners and raised capital - Bedrocan BV is not taking 2.5% - 7.5% - no, it is their new partners (us) that are taking the lion's share of 92.5% - 97.5% of the revenue from domestic production

We get to keep half of all the licensing revenues that Bedrocan Corp receives from their deals in S. America - that is not for work our present corporation does - it is revenue we could receive simply by going over their, finding some partners and exporting the brand. Give them the clones, the logos, the science and the production method, collect some checks

The story is, we are planning Bedrocan Brazil and Bedrocan Chile next

And all that is just the pharma brand play Canopy has going for it, it also has a large low cost production unit (Tweed Farms) and the largest by sales distributor in Canada - Tweed, $20 million in cash with a clear path to positive cash flow

Yeah, Canopy Growth is a perfect name - we on top and getting bigger everyday

Stinger: And if you screw up just this much, you'll be flying a cargo plane full of rubber dog shit out of Hong Kong!
Maverick: Yes, sir!